Discontinued — last reported Q2 '20

Current Liabilities

Lease Liability Payments - Remainder of Fiscal Year

West Pharmaceutical Services Lease Liability Payments - Remainder of Fiscal Year increased by 175.0% to $1.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.2%, from $900.00K to $1.10M. Over 3 years (FY 2020 to FY 2023), Lease Liability Payments - Remainder of Fiscal Year shows an upward trend with a 14.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2019
Last reportedQ2 2020

How to read this metric

Higher values indicate greater near-term cash outflows, impacting short-term liquidity and working capital.

Detailed definition

The total cash outflows required to satisfy operating and finance lease obligations for the remaining portion of the cur...

Peer comparison

Standard disclosure under ASC 842 lease accounting standards.

Metric ID: lease_liability_payments_remainder_fiscal_year

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$10.50M$10.30M$11.50M$11.70M$12.30M$15.90M$19.00M$18.30M$18.60M$19.10M$18.70M$19.50M$400.00K$200.00K$900.00K$700.00K$400.00K$1.10M
QoQ Change-1.9%+11.7%+1.7%+5.1%+29.3%+19.5%-3.7%+1.6%+2.7%-2.1%+4.3%-97.9%-50.0%+350.0%-22.2%-42.9%+175.0%
YoY Change+17.1%+54.4%+65.2%+56.4%+51.2%+20.1%-1.6%+6.6%-97.8%-99.0%-95.4%+75.0%+100.0%+22.2%
Range$200.00K$19.50M
CAGR-41.2%
Avg YoY Growth+12.5%
Median YoY Growth+21.2%

Lease Liability Payments - Remainder of Fiscal Year at Other Companies

Frequently Asked Questions

What is West Pharmaceutical Services's lease liability payments - remainder of fiscal year?
West Pharmaceutical Services (WST) reported lease liability payments - remainder of fiscal year of $1.10M in Q1 2026.
How has West Pharmaceutical Services's lease liability payments - remainder of fiscal year changed year-over-year?
West Pharmaceutical Services's lease liability payments - remainder of fiscal year increased by 22.2% year-over-year, from $900.00K to $1.10M.
What is the long-term trend for West Pharmaceutical Services's lease liability payments - remainder of fiscal year?
Over 3 years (2020 to 2023), West Pharmaceutical Services's lease liability payments - remainder of fiscal year has grown at a 14.7% compound annual growth rate (CAGR), from $12.40M to $18.70M.
What does lease liability payments - remainder of fiscal year mean?
The amount of lease payments due before the end of the current fiscal year.